PT  - JOURNAL ARTICLE
AU  - Kimura-Kuroda, J
AU  - Yasui, K
TI  - Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
DP  - 1988 Nov 15
TA  - The Journal of Immunology
PG  - 3606--3610
VI  - 141
IP  - 10
4099  - http://www.jimmunol.org/content/141/10/3606.short
4100  - http://www.jimmunol.org/content/141/10/3606.full
SO  - J. Immunol.1988 Nov 15; 141
AB  - We have identified and characterized nine antigenic epitopes on the E envelope of Japanese encephalitis virus (JEV) by using mAb. Passive administration of most of the anti-JEV mAb protected mice from i.v. challenge with 1.5 x 10(3) plaque-forming units of JEV, JaGAr-01 strain. Some mAb, which possess high neutralization activity in vitro, showed high protection, and JEV-specific N mAb 503 was found the most protective. Even an injection of 2.5 micrograms/mouse of mAb 503 protected all mice from JEV infection. Furthermore, an injection of about 200 micrograms of mAb 503 on day 5 postinfection protected 82% of the mice, even when JEV was detected in more than 85% of the infected mouse brains. Synergism of protection was observed with mixtures of several mAb directed against different epitopes. Although in a murine macrophage cell line, all of the mAb groups showed antibody-dependent enhancement (ADE) of JEV infectivity in vitro, and only two flavivirus cross-reactive mAb groups showed ADE of dengue virus type 2. The ADE of JEV by mAb seems not to be harmful for in vivo protection experiments, except for two mAb groups: mAb 302 and 201 showed little or no protective activity against JEV infection and, rather, caused early death in infected mice.